1-14 of 14
Authors: Johan Engdahl
Journal Article
External validation of a machine learning-based classification algorithm for ambulatory heart rhythm diagnostics in pericardioversion atrial fibrillation patients using smartphone photoplethysmography: the SMARTBEATS-ALGO study
EP Europace, Volume 27, Issue 4, April 2025, euaf031, https://doi.org/10.1093/europace/euaf031
Published: 17 February 2025
Journal Article
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates
EP Europace, Volume 27, Issue 2, February 2025, euaf030, https://doi.org/10.1093/europace/euaf030
Published: 15 February 2025
Journal Article
The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
EP Europace, Volume 26, Issue 10, October 2024, euae228, https://doi.org/10.1093/europace/euae228
Published: 09 September 2024
Journal Article
Validation of a novel smartphone-based photoplethysmographic method for ambulatory heart rhythm diagnostics: the SMARTBEATS study
EP Europace, Volume 26, Issue 4, April 2024, euae079, https://doi.org/10.1093/europace/euae079
Published: 27 March 2024
Journal Article
Screening for atrial fibrillation: all invitees are equal, but some are more equal than others?
EP Europace, Volume 25, Issue 5, May 2023, euad133, https://doi.org/10.1093/europace/euad133
Published: 16 May 2023
Journal Article
Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study
EP Europace, Volume 22, Issue 1, January 2020, Pages 58–65, https://doi.org/10.1093/europace/euz306
Published: 21 November 2019
Journal Article
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
EP Europace, Volume 22, Issue 1, January 2020, Pages 24–32, https://doi.org/10.1093/europace/euz255
Published: 17 September 2019
Journal Article
A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation
EP Europace, Volume 20, Issue FI_3, November 2018, Pages f306–f311, https://doi.org/10.1093/europace/euy045
Published: 24 April 2018
Journal Article
Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
EP Europace, Volume 19, Issue 10, October 2017, Pages 1650–1656, https://doi.org/10.1093/europace/eux002
Published: 01 March 2017
Journal Article
Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design
EP Europace, Volume 19, Issue 2, 1 February 2017, Pages 297–302, https://doi.org/10.1093/europace/euw319
Published: 07 December 2016
Journal Article
Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation
EP Europace, Volume 19, Issue 9, September 2017, Pages 1449–1453, https://doi.org/10.1093/europace/euw286
Published: 06 October 2016
Journal Article
Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
EP Europace, Volume 17, Issue 10, October 2015, Pages 1514–1517, https://doi.org/10.1093/europace/euv123
Published: 27 May 2015
Journal Article
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
EP Europace, Volume 17, Issue 7, July 2015, Pages 1023–1029, https://doi.org/10.1093/europace/euv083
Published: 13 April 2015
Journal Article
Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
EP Europace, Volume 15, Issue 1, January 2013, Pages 135–140, https://doi.org/10.1093/europace/eus217
Published: 11 July 2012
